---
title: "Alnylam Pharma (ALNY.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ALNY.US/norm.md"
symbol: "ALNY.US"
name: "Alnylam Pharma"
parent: "https://longbridge.com/en/quote/ALNY.US.md"
datetime: "2026-05-20T15:57:40.481Z"
locales:
  - [en](https://longbridge.com/en/quote/ALNY.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ALNY.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ALNY.US/norm.md)
---

# Alnylam Pharma (ALNY.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | 1.51 | 1.37 | 1.84 | -0.5074 | -0.1407 |
| ROE | 88.38% | 145.77% | 414.60% | -144.86% | -79.99% |
| Revenue | 1.17B | 1.10B | 1.25B | 773.69M | 594.19M |
| Net income | 205.99M | 186.42M | 251.08M | -66.28M | -18.25M |
| Operating income | 268.64M | 131.72M | 367.98M | -16.20M | 18.08M |
| Gross margin | 81.91% | 75.60% | 83.98% | 81.52% | 88.04% |
| Net margin | 17.65% | 16.99% | 20.10% | -8.57% | -3.07% |
| Profit quality | 381.02% | 80.53% | 113.19% | -10.54% | -15.03% |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 5.13B | 4.97B | 4.85B | 4.57B | 4.21B |
| Leverage | 4.77 | 6.29 | 20.74 | 18.22 | 36.50 |
| BVPS | 8.06 | 5.96 | 1.77 | 1.91 | 0.8858 |
| Turnover | 0.9176 | 0.8068 | 0.7089 | 0.5742 | 0.5842 |
| Cash & STI | 3.01B | 2.91B | 2.72B | 2.86B | 2.63B |
| Inv & Rec | 84.03M | 82.72M | 75.38M | 71.69M | 65.58M |
| LT assets | 707.56M | 708.06M | 693.14M | 692.19M | 695.92M |
| Net debt | -38.99M | 60.31M | 48.69M | -117.85M | 90.03M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 70.50M | 163.56M | 325.11M | 153.73M | -120.31M |
| Investing CF | -25.54M | -37.17M | 501.11M | -141.38M | 113.77M |
| Financing CF | 15.71M | 45.32M | -448.35M | 53.76M | 46.08M |
| Free CF | 37.43M | 35.91M | 135.59M | 160.54M | -45.36M |
| OCF coverage | 322.92% | 216.50% | 28.21% | 1075.56% | -1341.27% |
| Repaid & issued | - | -680000.00 | 646.37M | - | - |
| CapEx | -21.83M | -23.29M | -12.14M | -14.29M | -8.97M |